HCID 178467881、化合物 → HCID 178461152、化合物

HRID 990590

反応式

HRID 990590 の反応式
CCO.[CH3:4][C@@H:5]1[C@@H:19]2[C:14](=[C:15]([OH:34])[C@:16]3([OH:33])[C:24](=[O:25])[C:23]([C:26]([NH2:28])=[O:27])=[C:22]([OH:29])[C@@H:21]([N:30]([CH3:32])[CH3:31])[C@@H:17]3[C@H:18]2[OH:20])[C:12](=[O:13])[C:11]2[C:10]([OH:35])=[CH:9][CH:8]=[CH:7][C:6]1=2.O.Cl>CN1CCCC1=O>[CH3:4][C@@H:5]1[C@@H:19]2[C:14](=[C:15]([OH:34])[C@:16]3([OH:33])[C:24](=[O:25])[C:23]([C:26]([NH2:28])=[O:27])=[C:22]([OH:29])[C@@H:21]([N:30]([CH3:31])[CH3:32])[C@@H:17]3[C@H:18]2[OH:20])[C:12](=[O:13])[C:11]2[C:10]([OH:35])=[CH:9][CH:8]=[CH:7][C:6]1=2

参加物

3

実験手順

The biodegradable polymer of the present invention dissolved in N-methyl pyrollidone was loaded into a 1 ml syringe. Doxycycline hyclate was loaded into another 1 ml syringe to give a drug load of 8.5 percent doxycycline. The syringes were coupled together and mixed for 50 cycles. The syringe was then placed on a scale and tared. The composition containing doxycycline was then dropped into 5 ml phosphate buffer solution at a pH of 7.40 and a temperature of 37° C. The syringe was then placed back on the scale and the implant weight was recorded. This was repeated for each formulation four more times to give an n of five at each time point. The samples were then placed in an environmental shaker at 37° C. with a speed of 150 RPMs. At various time points, the phosphate buffer solution was decanted and the polymer implant was left in the vial. A fresh 5 ml of phosphate buffer solution was added to the precipitated polymer and placed back in the shaker. The phosphate buffer solution that was decanted was then analyzed by UV visibility for doxycycline content. Based upon the implant weight a theoretical amount of doxycycline was calculated. Drug release was then based upon this theoretical amount. Release data are depicted FIG. 4.

後処理

  1. customwas loaded into a 1 ml syringe

出典と根拠

ORDレコード
ord-cdaa262b5d964b5fbcc99d69bfd3abf2
出典データセット
uspto-grants-2002_10
特許番号
US06461631B1

関連ノート

読み込み中…